Kolon TissueGene, Inc. (KOSDAQ:950160)

Market Cap	2.87T
Revenue	n/a
Net Income	n/a
Shares Out	81.43M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	307,291
Average Volume	429,373
Open	38,900
Previous Close	38,900
Day's Range	37,550 - 39,450
52-Week Range	9,310 - 39,450
Beta	-0.59
RSI	58.70
Earnings Date	n/a

About Kolon TissueGene

Kolon TissueGene, Inc. develops cell therapies to target various orthopedic diseases and degenerative disorders. The company is developing cell therapies for osteoarthritis and musculoskeletal system disorders, as well as vet medicine. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. The company was founded in 1999 and is headquartered in Rockville, Maryland.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1999
• Employees: 29
• Stock Exchange: KOSDAQ
• Ticker Symbol: 950160